C6Z-15979-40680
4 vaccinations
9 coded responses
41 check-ins
8 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 871 / NM
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Registered in v-safe
-
2021-03-25
Dose 1 — Pfizer-BioNTech
- 2021-03-25
-
2021-03-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-27
Survey response — days 1–6 daily, dose 1MedDRA: Dysgeusia — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Intermittent metallic taste in mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Survey response — days 1–6 daily, dose 1MedDRA: Dysgeusia — Feeling: Good · Muscle or body achesFree text: Intermittent metallic taste in the mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-08
-
2021-04-14
Dose 2 — Pfizer-BioNTech
- 2021-04-14
-
2021-04-15
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia, Oropharyngeal pain — Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Metallic taste in mouth, mild sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Metallic taste, intermittentMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia — Feeling: Poor · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Metallic tasteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling, Itching · Muscle or body achesAdult check-in
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
-
2021-05-26
Survey response — day 42, dose 2MedDRA: Heavy menstrual bleeding — Feeling: Good · Be unable to do your normal daily activitiesFree text: My period was longer and heavier than normal. It lasted 8 days when my period is normally 5-6 days. A couple of days I was having to change my pad every hour or two. Normally I only need to change every 4-6 hours.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-14
Survey response — 3 months, dose 2MedDRA: Cough, Fatigue, Headache, Heavy menstrual bleeding, Nasal dryness, Pain, Reaction to previous exposure to any vaccine — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Fatigue, body aches, headache, cough, dry nose. Only for the last week. May be a summer cold. My first period after being fully vaccinated was heavy and long. The second one was back to normal.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-13
-
2021-12-15
Dose 3 — Pfizer-BioNTech
- 2022-04-14
- 2022-06-15
-
2022-10-08
Dose 4 — Pfizer-BioNTech
-
2022-10-08
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-09
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
-
2022-10-10
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2022-10-11
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-22
- 2022-10-29
- 2022-11-05
- 2022-11-12
-
2022-11-19
Survey response — day 42, dose 4MedDRA: Body temperature increased, Chills, Fatigue, Influenza, Pain, Pyrexia, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Alternating feverish and chills, body aches, congestion, runny nose, fatigue. Diagnosed with flu. Took last dose of tamiflu earlier today. Temp ranging from 98.3-99.6. covid test negative.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-19
Report sent to call center — day 42, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-11-21
-
2022-11-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-01-07
Survey response — 3 months, dose 4MedDRA: COVID-19, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-07
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-09
Call successfulCompleted over the phone
- 2023-04-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
| 4 | 2022-10-08 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 1
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Intermittent metallic taste in mouth
Systemic reaction (other): Intermittent metallic taste in the mouth
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Metallic taste in mouth, mild sore throat
Systemic reaction (other): Metallic taste, intermittent
Systemic reaction (other): Metallic taste
Release 8 — day 42, dose 2
Symptoms: My period was longer and heavier than normal. It lasted 8 days when my period is normally 5-6 days. A couple of days I was having to change my pad every hour or two. Normally I only need to change every 4-6 hours.
Release 9 — 3 months, dose 2
Symptoms: Fatigue, body aches, headache, cough, dry nose. Only for the last week. May be a summer cold. My first period after being fully vaccinated was heavy and long. The second one was back to normal.
Release 12 — day 42, dose 4
Symptoms: Alternating feverish and chills, body aches, congestion, runny nose, fatigue. Diagnosed with flu. Took last dose of tamiflu earlier today. Temp ranging from 98.3-99.6. covid test negative.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | · | · | ✓ |
| SD | Chills | ○ | ○ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasal dryness | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Reaction to previous exposure to any vaccine | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release